Thryv Therapeutics Announces Participation in Four Major Upcoming Investor Conferences
Hand-out
Press Releases
November 6, 2024

Thryv Therapeutics Announces Participation in Four Major Upcoming Investor Conferences

MONTREAL, Nov. 6, 2024 /PRNewswire/ - Thryv Therapeutics Inc., a clinical-stage biotechnology company pioneering novel therapies for cardiovascular diseases, is pleased to announce its participation in four prominent healthcare investor

bradford

The Bradford Era

Local & Social